News


Resident News

ProteoFormiX Awarded € 265K VLAIO Research Grant

By JLABS

Read full story
Resident News

S-Biomedic is Gearing up for Significant Growth

By JLABS

Read full story
Resident News

Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future

By JLABS

Read full story
Resident News

AlphaBiomics wins award to validate its IBD biologic therapy response predictor RxSelex

By JLABS

Read full story
In the media

Uncovering global opportunities: a conversation with Jennifer Hamilton of Johnson & Johnson Innovation

By Highline Beta

Read full story
Other news

Knowledge for Growth 2018 Recap

By Janssen Belgium

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

By JLABS

Read full story
In the media

J&J extends its JLABS incubator scheme to Europe

By Phil Taylor

Read full story
In the media

Belgium chosen for first J&J ‘JLABS’ incubator in Europe

By Andrew McConaghie

Read full story
Other news

Next stop, Europe! @JNJInnovation introduces @JLABS in Belgium

By JLABS

Read full story
In the media

Johnson & Johnson opens first European JLABS incubator

By Nick Paul Taylor

Read full story
Other news

Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates

By JLABS

Read full story
Other news

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

By JLABS

Read full story
Other news

Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline

By JLABS

Read full story